The U.S. Food and Drug Administration has decided that approximately 60 million doses of the Johnson & Johnson Covid vaccine will be discarded due to possible contamination with another vaccine. The doses were produced in the Baltimore plant already under the eye of the storm for other problems. The FDA, reports the New York Times, is therefore evaluating whether to allow the distribution in the US or other countries of at least 10 million doses of these vaccines but with a warning, one which states that the authorities cannot guarantee that manufacturing plant has followed good practices. Establishment whose reopening, among other things, has not yet been decided after a two-month stop. For now there are no doses destined for Europe.
*** Subscribe to the Special Coronavirus Newsletter
“The European Union authorities are aware that a batch of the active ingredient for the Janssen vaccine against Covid-19 has been contaminated with materials for another vaccine manufactured at the same site.” The European Medicines Agency (EMA) made it known, underlining that the contamination took place in Maryland, in the United States, in a plant owned by Emergent Biosolutions: “The lot in question was not destined for the EU market – has added – based on available information, vaccine batches released in the EU are not affected by cross-contamination. However, as a precaution and to safeguard the quality of the vaccines, the supervisory authorities have recommended not to release batches of vaccines containing the active ingredient manufactured at approximately the same time as contamination occurred. ‘